Transfer factor as an approach to the treatment of immune deficiency disease
- PMID: 1096988
Transfer factor as an approach to the treatment of immune deficiency disease
Abstract
Use of transfer factor in the treatment of chronic mucocutaneous candidiasis is discussed. The clinical experience in treating 2 patients with different clinical expressions of the syndrome and their different responses to treatment with repeated injections of transfer factor given in conjunction with amphotericin-B are reported. Results indicate that this form of therapy is a safe and effective way of restoring cell-mediated immunity to Candida and successfully treating some patients with chronic mucocutaneous candidiasis.
Similar articles
-
Use of transfer factor in patients with depressed cellular immunity and chronic infection.Birth Defects Orig Artic Ser. 1975;11(1):431-5. Birth Defects Orig Artic Ser. 1975. PMID: 1096987
-
Restoration of cell-mediated immune responses with transfer factor.Birth Defects Orig Artic Ser. 1975;11(1):441-4. Birth Defects Orig Artic Ser. 1975. PMID: 1096989
-
[Treatment of immunologic deficiency conditions by means of transfer factor].Pediatr Pol. 1975 Nov;50(11):1393-7. Pediatr Pol. 1975. PMID: 1103073 Review. Polish. No abstract available.
-
Reconstitution of defective cellular immunity with foetal thymus and dialysable transfer factor. Long-term studies in a patient with chronic mucocutaneous candidiasis.Clin Exp Immunol. 1976 Mar;23(3):414-28. Clin Exp Immunol. 1976. PMID: 947642 Free PMC article.
-
[Classification of chronic mucocutaneous candidiasis with observations on the clinical picture and its therapy].Hautarzt. 1974 Apr;25(4):159-65. Hautarzt. 1974. PMID: 4603392 Review. German. No abstract available.
Cited by
-
Low-dose amphotericin B and murine dialyzable spleen extracts protect against systemic candida infection in mice.Clin Dev Immunol. 2013;2013:194064. doi: 10.1155/2013/194064. Epub 2013 Sep 10. Clin Dev Immunol. 2013. PMID: 24106515 Free PMC article.